Semin Thromb Hemost 2003; 29(2): 171-174
DOI: 10.1055/s-2003-38832
Copyright © 2003 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA. Tel.: +1(212) 584-4662

Coagulation Factor Deficiencies and Pregnancy Loss

Aida Inbal1 , Laszlo Muszbek2
  • 1Associate Professor, and Acting Director, Institute of Thrombosis and Hemostasis, Sheba Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Israel
  • 2Department of Clinical Biochemistry and Molecular Pathology, Medical and Health Science Center, University of Debrecen, Hungary
Further Information

Publication History

Publication Date:
23 April 2003 (online)

ABSTRACT

Of all the coagulation factor deficiencies, only deficiency of factor XIII (FXIII) and fibrinogen are associated with pregnancy loss. FXIII deficiency and a complete or partial deficiency of fibrinogen are associated with bleeding since childhood, impaired wound repair, and recurrent spontaneous abortions. Both FXIII and fibrinogen play an essential role in placental implantation and maintenance of pregnancy. The causes of miscarriages in FXIII or fibrinogen-deficient women is discussed and an appropriate treatment advocated.

REFERENCES

  • 1 Schwartz M L, Pizzo S V, McKee P A. Human factor XIII from plasma and platelets.  J Biol Chem . 1973;  248 1395-1407
  • 2 Muszbek L, Yee V C, Hevessy Z. Blood coagulation factor XIII: structure and function.  Thromb Res . 1999;  94 271-305
  • 3 Fisher S, Rikover M, Naor S. Factor 13 deficiency with severe hemorrhagic diathesis.  Blood . 1966;  28 34-39
  • 4 Anwar T, Miloszewski K. Factor XIII deficiency.  Br J Haematol . 1999;  107 468-484
  • 5 Ádány R, Muszbek L. Immunohistochemical detection of Factor XIII subunit a in histiocytes of human uterus.  Histochemistry . 1989;  91 169-174
  • 6 Asahina T, Kobayashi T, Okada Y. et al . Studies on the role of adhesive proteins in maintaining pregnancy.  Horm Res . 1998;  50(Suppl 2) 37-45
  • 7 Ádány R, Glukhova M, Kabakov A Y. et al . Characterization of connective tissue cells containing factor XIII subunit a.  J Clin Pathol . 1988;  41 49-56
  • 8 Kappelmayer J, Bacsko G, Kelemen E. et al . Onset and distribution of factor XIII-containing cells in the mesenchyme of chorionic villi during early phase of human placentation.  Placenta . 1994;  15 613-623
  • 9 Muszbek L, Ádány R, Kávai M. et al . Monocytes of patients congenitally deficient in plasma factor XIII lack factor XIII subunit A antigen and transglutaminase activity.  Thromb Haemost . 1988;  59 231-235
  • 10 Rodeghiero F, Castaman G C, Di Bona E. et al . Successful pregnancy in a woman with congenital factor XIII deficiency treated with substitute therapy.  Blut . 1987;  55 45-48
  • 11 Boda Z, Pfliegler G, Muszbek L. et al . Congenital factor XIII deficiency with multiple benign breast tumors and successful pregnancy with substitutive therapy.  Haemostasis . 1989;  19 348-352
  • 12 Kobayashi T, Terao T, Kojima T. et al . Congenital factor XIII deficiency with treatment of factor XIII concentrate and normal vaginal delivery.  Gynecol Obstet Invest . 1990;  29 235-238
  • 13 Burrows R F, Ray J G, Burrows E A. Bleeding risk and reproductive capacity among patients with factor XIII deficiency: a case presentation and review of the literature.  Obstet Gynecol Survey . 2000;  55 103-8
  • 14 Wartiovaara J, Leivo I, Virtanen I. et al . Cell surface and extracellular matrix glycoprotein fibronectin. Expression in embryogenesis and in teratocarcinoma differentiation.  Ann NY Acad Sci . 1978;  312 132-141
  • 15 Vicovac L, Aplin J D. Epithelial-mesenchymal transition during trophoblast differentiation.  Acta Anat . 1966;  156 202-216
  • 16 Kobayashi T, Asahina T, Okada Y. et al . Studies on the localization of adhesive proteins associated with the development of extravillous cytotrophoblast.  Trophoblast Res . 1999;  13 35-53
  • 17 Asahina T, Kobayashi T, Okada Y. et al . Maternal blood coagulation factor XIII is associated with the development of cytotrophoblastic shell.  Placenta . 2000;  21 388-393
  • 18 Brackmann H H, Egbring R, Feister A. et al . Pharmacokinetics and tolerability of factor XIII concentrates prepared from human placenta or plasma: A crossover randomized trial.  Thromb Haemost . 1995;  74 622-625
  • 19 Mikkola H, Muszbek L, Laiho E. et al . Molecular mechanism of a mild phenotype in coagulation factor XIII (FXIII) deficiency: a splicing mutation permitting partial correct splicing of FXIII A-subunit mRNA.  Blood . 1997;  89 1279-1287
  • 20 Hayano Y, Ima N, Kasaraura T. Studies on the physiologic changes of blood coagulation factor XIII during pregnancy and their significance.  Acta Obstet Gynaecol Jpn . 1982;  34 469-477
  • 21 Nossel H L, Lanzkowsky P, Levy S. et al . A study of coagulation levels in women during labor and their newborn infants.  Thromb Diath Haemorrhag . 1966;  16 185-197
  • 22 Biland L, Duckert F. Coagulation factors in the newborn and his mother.  Thromb Diath Haemorrhag . 1973;  29 644-651
  • 23 Coopland A, Alkjaersig N, Fletcher A P. Reduction in plasma factor XIII (fibrin stabilizing factor) concentration during pregnancy.  L Lab Clin Med . 1969;  73 144-153
  • 24 van Wersch W J, Vooijs M E, Ubachs J M. Coagulation factor XIII in pregnant smokers and non-smokers.  Int J Clin Lab Res . 1997;  27 68-71
  • 25 Stirling Y, Woolf L, North W RS. et al . Haemostasis in normal pregnancy.  Thromb Haemost . 1984;  52 176-182
  • 26 Ogasawara M S, Aoki K, Katano K. et al . Factor XII but not protein C, protein S, antithrombin III, or factor VIII is a predictor of recurrent miscarriage.  Fertil Steril . 2001;  75 916-919
  • 27 Galanakis D K. Fibrinogen anomalies and disease. A clinical update.  Hematol Oncol Clin N Am . 1992;  6 1171-1187
  • 28 Doolittle R F. The molecular biology of fibrin. In: Stamatoyannopoulos GS, Nienhuis AW, Majerus PW, Varmus H, eds. The Molecular Basis of Blood Diseases Philadelphia, PA: WB Saunders 1994: 701-723
  • 29 Bennett J S. Integrin structure and function in hemostasis and thrombosis.  Ann NY Acad Sci . 1991;  614 214-228
  • 30 Mosesson M W. Dysfibrinogenemia and thrombosis.  Semin Thromb Hemost . 1999;  25 311-319
  • 31 Ridgway H J, Brennan S O, Faed J M, George P M. Fibrinogen Otago: a major α chain truncation associated with severe hypofibrinogenaemia and recurrent miscarriage.  Br J Haematol . 1997;  98 632-639
  • 32 Suh T T, Holmback K, Jensen N. et al . Resolution of spontaneous bleeding events but failure of pregnancy in fibrinogen-deficient mice.  Genes Dev . 1995;  9 2020-2033
  • 33 Inamoto Y, Terao T. First report of a case of congenital afibrinogenemia with successful delivery.  Am J Obstet Gynecol . 1985;  153 803-804
  • 34 Gilabert J, Reganon E, Vila V. et al . Congenital hypofibrinogenemia and pregnancy: obstetric and hematological management.  Gynecol Obstet Invest . 1987;  24 271-276
  • 35 Ingram G IC, McBrien D J, Spencer H. Fatal pulmonary embolus in congenital fibrinopenia. Report of two cases.  Acta Hematol . 1966;  35 56-62
  • 36 MacKinnon H H, Fekete J F. Congenital afibrinogenemia: vascular changes and multiple thromboses induced by fibrinogen infusions and contraceptive medication.  J Can Med Assoc . 1971;  140 597-599
  • 37 Beck E A. Congenital abnormalities of fibrinogen.  Clin Haematol . 1979;  8 169-181